Meningiomas are the most common intracranial tumors. Yet, only few controlled clinical trials
have been conducted to guide clinical decision making, resulting in variations of …

Neuroimaging plays a central role but still often falls short on essential questions. Advanced
imaging acquisition and analysis techniques hold great promise for answering such …

Meningiomas are the most common primary intracranial neoplasm, accounting for
approximately 40% of all primary brain tumors. The incidence of meningioma increases with …

While MRI has become the imaging modality of choice for intracranial meningiomas, no
radiologic reporting guidance exists to date that relies on a systematic collection of …

Gadolinium-based contrast agents (GBCA) are essential for diagnostic MRI examinations.
GBCA are only used in small quantities on a per-patient basis; however, the acquisition of …

ABSTRACT BACKGROUND AND PURPOSE: Gadolinium-based contrast agents are widely
used for meningioma imaging; however, concerns exist regarding their side effects, cost …

OBJECTIVE Patients with meningiomas require serial MRI for surveillance of tumor size and
growth rate. The cost and resource requirements for contrast-enhanced MRI include …

OBJECTIVE. The purpose of this study was to determine if contrast enhancement is
necessary for MRI surveillance of clinical T1a (cT1a) solid renal masses. MATERIALS AND …

Meningiomas are the most common neoplasms of the central nervous system, accounting
for approximately 40% of all brain tumors. Surgical resection represents the mainstay of …

Background Contrast-enhanced magnetic resonance imaging (MRI) is the imaging modality
routinely used to follow up patients who have undergone surgical resection of brain …